Home/Filings/4/0000899243-23-008289
4//SEC Filing

Sorensen Mel 4

Accession 0000899243-23-008289

CIK 0001563577other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 8:30 AM ET

Size

5.0 KB

Accession

0000899243-23-008289

Insider Transaction Report

Form 4
Period: 2023-03-10
Sorensen Mel
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-03-10$1.68/sh+100,000$168,120332,044 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.635 to $1.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1
  • filerCIK 0001444783

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:30 AM ET
Size
5.0 KB